Form 4: Centessa Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
David M. Chao, Chief Administrative Officer of Centessa Pharmaceuticals plc, disposed of shares to cover tax withholding obligations related to vesting restricted share units.
Summary
- On February 1, 2025, David M. Chao, Chief Administrative Officer of Centessa Pharmaceuticals plc, disposed of 13,324 ordinary shares.
- The shares were sold at a price of $16.92 per share.
- This transaction was to cover tax withholding obligations related to the vesting of restricted share units.
- Following the transaction, Chao directly owns 228,507 ordinary shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a routine transaction to cover tax obligations.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This transaction is a common occurrence where executives sell shares to cover tax obligations related to vesting equity.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine sale of shares to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/01/2025 | Date of transaction: disposal of shares to cover tax obligations. |
| 02/04/2025 | Date of signature on the Form 4 filing. |
Keywords
Centessa Pharmaceuticals, CNTA, Form 4, David M. Chao, Share Disposal, Tax Withholding, Officer Transaction, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.